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Effect of alpha and beta-adrenergic stimulation on renal water
excretion and medullary tissue cyclic AMP in intact and diabetes
insipidus rats. The present study examined the effect of isoprotere-
nol and norepinephrine on renal water excretion and cyclic AMP
concentration in renal medullary tissue in water-diuresirig intact
rats and rats with congenital pituitary diabetes insipidus (Dl). The
effects of isoproterenol on blood pressure (13P) and glomerular
filtration rate (GFR) were similar in the intact and Dl rats. In
intact rats, isoproterenol reversed the water diuresis, increasing
urinary osmolality (U0,,,) from 151 13 to 491 + 96 mOsm/
kg of water (P < 0.005) as medullary cyclic AMPconcentra-
tion increased from 4.7 + 0.6 to 13.9 + 1.5 pmoles/mg of protein
(P < 0.001). In rats with Dl, isoproterenol did not significantly
alter U0 (192 16 to 212 II mOsm/kg of water or
medullary cyclic AMP (6.! 1.3 to 4.5 0.6 pmoles/mg of
protein). The administration of exogenous vasopressin increased
U0,,,, and medullary cyclic AMP in both the intact and Dl rats.
The effects of norepinephrine on BP and GFR were similar in
intact and Dl rats receiving a constant infusion of vasopressin. In
intact rats, norepinephrine decreased U0,,, from 985 189 to 295
+ 25 mOsm/kg of water (P < 0.02) as medullary cyclic AMP
decreased from 6.6 0.5 to 2.1 + 0.2 pmoles/mg of protein (P <
0.001). In Dl rats receiving vasopressin, norepinephrine was not
associated with a significant decrease in either U0,,, (408 + 33.3 to
538 + 71.8 mOsm/kg of water) or medullary cyclic AMP (8.1
+ 1.2 to 14.1 + 2.0 pmoles/mg of protein). The present results,
therefore, indicate that the primary in vivo effectof isoproterenol
and norepinephrine to alter U0,,. and medullary cyclic AM P in the
anesthetized rat is dependent on the modulation of endogenous
vasopressin release.
Effet de Ia stimulation alpha et beta adrénergique sur l'excrétion
rénale d'eau et I'AMP cyclique tissulaire chez le rat intact ou atteint
de diabète insipide. Ce travail a eu pour but d'étudier !'effet de
l'isoprotérenol et de a norépinêphrine sur I'excrétion rénale d'eau
et Ia concentration médullaire d'AMP cyclique chez des rats en
diurèse aqueuse intacts ou atteints de diabéte insipide hypophy-
saire (DI) congenital. Les effets de l'isoprotérCnol sur Ia pression
artérielle et Ic debit de filtration glomerulaire (GFR) sont scm-
blables chez les rats intacts et Dl. Chz es rats intacts,
l'isoprotCrcnol about Ia diurèse aqueuse, 'osmolalité urinaire
(Uo,m) augmente de 151 + 13 it 491 + 96 mOsm/kg d'eau (P <
0,005) pendant que Ia concentration médullaire d'AMP cyclique
augmente de 4,7 + 0,6 a 13,9 + 1,5 pmoles/mg de proteines (P <
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0,001). Chez les rats Dl I'isoprotérenol ne modifie pas signifi-
cativement Uo,m (192 16 it 212 11 mOsm/kg d'eau) ou
I'AMP cyclique médullaire (6,1 + 1,3 a 4,5 0,6 pmoles/mg de
protéines). L'admin istration de vasopressine exogCne augmente
Uo,m et l'AMP cyclique mCdullaire dans les deux groupes de rats.
Les diets de Ia norépinéphrine sur Ia pression artérielle et GFR
sont semblables chez les rats intacts et Dl qui recoivent une per-
fusion de vasopressine it debit constant. Chez les rats intacts, Ia
norCpinéphrine fait baisser Uo,m de 985 + 189 it 295 25 mOsm/
kg d'eau pendant que I'AMP cyclique médullaire diminue
de 6,6 + 0,5 a 2, I + 0,2 pmoles/mg de protéines (P < 0,001). Chez
les rats DI qui reçoivent de Ia vasopressine Ia norépinCphrine ne
determine de diminution significative ni de Uo,m (408 + 33,3 it 538
+ 71,8 mOsm/kg d'eau) ni de I'AMP cyclique médullaire (8,1
+ 1,2 a 14,1 + 2,0 pmoles/mg de protéines). Ces résultats in-
diquent done que l'effet primaire in vivo de l'isoprotCrenol et de Ia
norépinéphrine, qui est une modification de Uo,m et de I'AMP
cyclique médullaire chez le rat anesthCsié, depend de Ia modulation
de Ia liberation de vasopressine endogène.
The mechanism whereby norepinephrine and
isoproterenol alter renal water excretion has been the
focus of considerable investigation. The antidiuretic
effect of isoproterenol has been found to be abolished
by beta adrenergic blockade [I], and the diuretic
effect of norepinephrine is abolished by alpha
adrenergic blockade [2]. There also is considerable
experimental evidence which demonstrates that these
opposing effects of alpha and beta adrenergic stimu-
lation on water excretion can be dissociated from
alterations in glomerular filtration, renal blood flow,
renal perfusion pressure, renal innervation, and so-
lute excretion rate [3—6]. These findings are compat-
ible either with a direct effect of these catecholamines
on renal tubules or an effect mediated by alterations
in endogenous vasopressin release.
Several studies have provided evidence in support
of a vasopressin-mediated mechanism. Recent studies
have been performed in dogs which had been hypo-
physectomized acutely to remove the pituitary
source of vasopressin release. The antidiuretic effect
of isoproterenol infused i.v. was found to be virtually
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abolished in these steroid-replaced hypophysecto-
mized dogs undergoing a water diuresis [5]. The wa-
ter diuresis associated with i.v. norepinephrine also
was not demonstrable in steroid-replaced hypophy-
sectomized dogs receiving an exogenous infusion of
vasopressin [6]. Furthermore, these effects of alpha
and beta adrenergic stimulation on renal water excre-
tion were not demonstrable in baroreceptor-dener-
vated animals which had an intact pituitary source of
vasopressin [7, 8]. These latter results were inter-
preted to indicate that catecholamines alter vasopres-
sin release by influencing baroreceptor tone.
These above studies [5—8], therefore, indicate that
the effects of alpha and beta adrenergic stimulation
on renal water excretion are mediated, at least in
part, by alterations in vasopressin release. These re-
suits do not exclude, however, an additional effect of
catecholamines on the renal tubule. In this regard,
several in vitro studies have demonstrated an inter-
action between catecholamines and the effect of vaso-
pressin to stimulate cyclic adenosine 3', 5' mono-
phosphate (cyclic AMP) generation and to enhance
the osmotic movement of water in anuran mem-
branes [9—li]. While the argument could be made
that these in vitro conditions may not simulate the in
vivo setting, there are also some in vivo results which
suggest an effect of catecholamines which is inde-
pendent of vasopressin. First, a small antidiuretic
effect has been observed with beta adrenergic stimu-
lation in rats suffering from diabetes insipidus (DI)
[12]. The effects of isoproterenol on arterial pressure
and renal hemodynamics, however, were not assessed
in this latter study. A water diuresis also has been
observed with alpha adrenergic stimulation in water-
loaded patients receiving submaximal doses of vaso-
pressin [13]. In this latter study, however, the endog-
enous source of vasopressin may not have been to-
tally suppressed, and the results have not been
reproducible in patients with pituitary DI [14].
In the present study, experiments were designed to
examine further the mechanisms whereby cate-
cholamines alter renal water excretion. Studies were
performed in intact Sprague-Dawley rats and rats
with DI. These two different strains of rats were used
since a vasopressin-mediated effect of catecholamines
would be expected to be observed in the intact
Sprague-Dawley but not in the DI rats. The response
to i.v. norepinephrine or isoproterenol on renal and
systemic hemodynamics and renal water excretion
were assessed in these two strains of rats. Experi-
ments were also performed in which kidneys were
snap-frozen and cyclic AMP content in the medulla
measured before or after catecholamine administra-
tion.
The results demonstrate that the antidiuresis asso-
ciated with beta adrenergic stimulation in intact rats
is accompanied by an increase in renal medullary
cyclic AMP. Although the systemic and renal he-
modynamic alterations were similar, these effects
could not be reproduced in the rats with DI. Sim-
ilarly, the diuresis associated with alpha adrenergic
stimulation was accompanied by a decrease in renal
medullary cyclic AMP in intact rats. In rats with DI
receiving an exogenous infusion of submaximal doses
of vasopressin, however, norepinephrine neither in-
creased water excretion nor diminished medullary
cyclic AMP. These results, therefore, indicate that the
in vivo effects of alpha and beta adrenergic stimula-
tion to exert opposing results on renal water excre-
tion in the rat are dependent on the presence of
endogenous vasopressin and are mediated by changes
in medullary cyclic AMP.
Methods
Experiments were performed in Sprague-Dawley
rats or Brattleboro rats with congenital DI. In both
strains the weights of the rats ranged from 200 to 300
g. The Brattleboro rats were homozygous for DI, as
indicated by excretion of more than 50% of their
body weight as urine per day and urinary osmolality(Uom) of 250 mOsm/kg or less. All rats were
maintained on Purina laboratory rat chow and fluid
ad lib prior to the experiments.
At the time of the experiments, the rats were
anesthetized i.p. with 10 mg/100 g of body wt of
mactin. The jugular veins were catheterized with PE-
50 tubing to allow the i.v. infusion of solutions. A
femoral artery also was catheterized to allow blood
sampling and arterial pressure measurements. Arte-
rial blood pressures were measured by a pressure
transducer (Statham) and the results were recorded
continuously on a multichannel recorder (Hewlett-
Packard, model 7702B); mean arterial pressures were
calculated electronically. Inulin in isotonic saline was
infused continuously throughout the experiments in a
concentration to yield plasma levels of 20 mg/lOO ml
and, thus, to allow clearance measurements as an
index of glomerular filtration rate (GFR). Timed
urine collection periods (10 to 30 mm) were made
through a polyethylene cannula which was inserted
into the bladder by a suprapubic incision. The experi-
ments were carried out according to the following
protocols.
Isoproterenol studies in water-diuresing Sprague-
Dawley rats (Group 1). In this group of rats, a water
diuresis was established by infusing 0.45% saline at a
rate of 5 ml/l00 g of body wt per hr. The experiments
were commenced when the Uogmhad stabilized below
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150 mOsm/kg of water. A series of three or four
control clearance periods were obtained, and then
isoproterenol was infused i.v. at a constant rate of
0.0625 tg/100 g of body wt per mm. When urine flow
and blood pressure had again stabilized, a further
series of three or four clearance periods were ob-
tained.
Two additional sets of intact, water-diuresing rats
were prepared in the same manner as described above
except that their kidneys were removed rapidly
through a midline incision either during the initial
control period or 50 to 60 mm after the start of the
infusion of isoproterenol so that renal tissue content
of cyclic AMP could be measured. The kidneys were
incised sagittally and immediately placed in liquid
nitrogen. The elapsed time between performance of
the abdominal incision and cross-clamping the renal
pedicles was about 10 sec. The time between removal
of the kidneys and freezing was 10 to 15 sec. While
the tissue was still frozen, the cortex and medulla
were separated. The medullary tissue was immedi-
ately transferred in the frozen state to separate tubes
containing 1.5 ml of 10% trichloroacetic acid and
homogenized. Tissues from each kidney were han-
dled separately. The homogenates were centrifuged
at 12,000 rpm for 30 mm in a refrigerated centri-
fuge (Sorval RC-3) at 4°C. The supernatants were
decanted and the pellets saved for determination of
protein content by the biuret method [15]. The super-
natant of each specimen was then extracted five times
with five volumes of ether. Duplicate SO-tl aliquots
were then assayed for cyclic AMP content by the
method of Gilman [16]. The content of cyclic AMP
of each tissue sample was expressed as pmoles of
cyclic AMP per mg of tissue protein.
Isoproterenol studies in diabetes insipidus (DI) rats
(Group 2). These animals were studied in the same
way as the intact rats in Group 1. A constant infusion
of 0.45% saline was given at a rate of 5 ml/100 g of
body wt per hr throughout the study. The same
length of time (1.5 to 2 hr) was allowed between the
start of this infusion and the beginning of the control
clearance periods. The dose of the isoproterenol in-
fusion was the same as in the Group 1 studies, as was
the duration of the control and infusion periods. As
in the Group 1 studies, kidneys were removed, snap-
frozen, and renal tissue cyclic AMP content mea-
sured in the control and isoproterenol infusion peri-
ods.
Effects of exogenous vasopressin on water-diuresing
Sprague-Dawley and DI Rats (Group 3). This protocol
was also the same as in Groups I and 2, except
instead of the isoproterenol infusion, aqueous vaso-
pressin was given i.v. in a bolus dose of 50 U to
water-diuresing Sprague-Dawley and DI rats. Renal
tissue cyclic AMP content was measured in separate
groups of rats before and 20 to 30 mm after the bolus
dose of vasopressin.
Norepineph rine studies in Sprague- Dawley rats
(Group 4). The anesthesia, surgical preparation, and
clearance measurements were performed in this
group in the same way as in the preceding Groups I
to 3. The difference between the preparation of these
animals was that a water diuresis was not established
at the onset of the experiment. Instead of the 0.45%
saline given in the Groups I to 3 studies, normal
saline was given at the slower rate of 0.03 ml/lOO g of
body wt per mm.
After a series of three or four control clearance
periods, the rats were given a constant i.v. infusion of
norepinephrine (0.15 g/100 g of body wt per mm)
for 50 to 60 mm. When urine flow, Uosm, and blood
pressure had stabilized, a further series of clearance
periods were obtained.
As in the isoproterenol studies, separate groups of
rats in the norepinephrine studies were killed either
during the control period or during the infusion of
norepinephrine. The kidneys were rapidly removed,
frozen, dissected, and analyzed for tissue protein and
cyclic AMP content in the medulla.
Norepinephrine studies in DI rats (Group 5). These
animals underwent the same anesthetic and surgical
preparation as the intact rats in Group 4. They also
received a normal saline infusion at the same con-
stant rate (0.03 ml/100 g of body wt per mm)
throughout the study. In order to establish a urine
concentration similar to that of the control period in
the Group 4 rats, a constant i.v. infusion of aqueous
vasopressin (0.02 mU/100 g of body wt per hr) was
started 30 to 60 mm before the beginning of the first
control period and was continued throughout the
study. When urine flow and U05m had stabilized, a
series of three or four control clearance periods were
obtained. Then, a constant infusion of norepineph-
rine was given at a rate of 0.15 tg/100 g/min for 50 to
60 mm, as in Group 4, and three or four additional
clearance periods were obtained.
In two additional sets of Dl rats, removal of the
kidneys was performed either during the control
or 50 to 60 mm after the norepinephrine infusion
for tissue cyclic AMP analysis.
Biochemical analysis. Urine and plasma samples
were analyzed for inulin by methods previously de-
scribed by this laboratory [17]. Uosm was measured
with an osmometer (Advanced Instruments).
Statistical analysis. For the comparison of data
between two groups, Student's t test for unpaired
values was used. Comparisons of more than two
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groups of data were evaluated by the two-tailed anal-
ysis of variance method [18].
Results
Effects of isoproterenol and vasopressin in water-
diuresing intact Sprague-Dawley and DI rats (Groups 1
to 3). The i.v. isoproterenol decreased arterial blood
pressure (BP) significantly in both Sprague-Dawley
and DI rats. At the same time, there was a reduction
in GFR in both groups of animals; this fall, however,
reached a level of statistical significance only in the
group of DI rats (Table 1, A). In spite of these similar
changes in BP and GFR, the effects of isoproterenol
Ofl U08m and medullary cyclic AMP were quite differ-
ent. Uosm increased from 151 13 (sEM) to 491 96
mOsm/kg of water (P < 0.005) in the Sprague-
Dawley rats (N = 7). This antidiuresis was asso-
ciated with a medullary cyclic AMP concentra-
tion of 4.7 0.6 pmoles/mg of protein in the water-
diuresing Sprague-Dawley rats (N = 13 kidneys) and
13.9 1.5 pmoles/mg of protein in the Sprague-
Dawley rats receiving isoproterenol (P < 0.001; N =
20 kidneys). The results in these intact rats are shown
in Figure 1. For comparison, the response of the
intact rats to 50-tU bolus of vasopressin also is dem-
onstrated in Figure 1. With vasopressin, the Uosm
in these intact Sprague-Dawley rats increased signifi-
cantly from 172 + 22.6 to 417 56.8 mOsm/kg of
water (P < 0.02; N = 6 animals). With the vasopres-
sin administration, the medullary cyclic AMP was
11.3 2.0 pmoles/mg of protein (N = 11 kidneys) a
value significantly higher than the 4.7 pmoles/mg of
protein measured in the water-diuresing Sprague-
Dawley rats (P < 0.01). BP and GFR were not signif-
icantly altered by the administration of vasopressin
(Table I, B).
In the DI rats, the results were quite different. The
Uosm did not change significantly (192 16 to 212
11 mOsm/kg of water with the isoproterenol in-
fusion (N = 5 animals). Medullary cyclic AMP also
Table 1. Effect of isoproterenol, vasopressin, and norepinephrine
did not change significantly with the isoproterenol
infusion (N = 9 kidneys) as compared to the control
studies (4.5 0.6 to 6.1 1.3 pmoles/mg of protein;
N = 8 kidneys). These results in the DI rats are
shown in Figure 2. For comparison, the response of
the DI rats to the exogenous administration of 50 zU
of vasopressin also is plotted in Figure 2. With vaso-
pressin, the Uogm in these DI rats increased signifi-
cantly from 187 9 to 344 34 mOsm/kg (P <
0.02; N = 4 animals). After vasopressin administra-
tion to the DI rats, the renal medullary cyclic AMP
was 8.1 1.2 pmoles/mg of protein (N = 8 kidneys),
a value that was significantly higher than the 4.5
0.22 pmoles/mg of protein measured in the control
group of DI rats (P <0.005). The BP and GFR were
not significantly altered by vasopressin (Table 1 B).
Effects of norepinephrine in intact rats and DI rats
receiving an exogenous infusion of vasopressin (Groups
4 and 5). Norepinephrine infused i.v. increased arte-
rial BP significantly both in intact and DI rats. At the
same time, there were no significant alterations in
GFR in either the intact or DI group of rats (Table
I, C). The Uosm decreased from 985 189 to 295
25 mOsm/kg of water (P < 0.02) during the nor-
epinephrine infusion in the intact rats (N = 7 ani-
mals). Medullary cyclic AMP in the intact rats was
6.6 0.5 pmoles/mg of protein without norepineph-
rine (N = 9 kidneys) and 2.1 0.2 pmoles/mg of
protein during norepinephrine (N = 7 kidneys); these
values were significantly different at the P < 0.001
level. The mean results for Uosm and medullary cyclic
AMP values in the intact rats are shown in Figure 3.
The i.v. norepinephrine in the DI rats receiving
exogenous vasopressin did not decrease Uosm (408
33.3 to 538 71.8 mOsm/kg of water) (N = 5
animals), The medullary cyclic AMP also was not
lower in the norepinephrine-treated rats as compared
to control rats (N = 10 kidneys). In fact, the medul-
lary cyclic AMP levels were 8.1 1.2 pmoles/mg of
protein without and 14.1 2.0 pmoles/mg of protein
on arterial blood pressure (BP) and glomerular filtration rate (GFR)
in intact and diabetes insipidus rats
Intact rats Diabetes insipidus rats
A.
BP, mm Hg
GFR,m//min
(N 7)
(N = 5)
Control
125.0 5.8
1.6 0.2
<0.05
NS
!soproterenol
111.0 + 9.8
1.1 0.1
(N = 5)(N = 5)
Control
136.0 9.2
1.0 0.1
<0.0!
<0.025
Isoproterenol
128.0 + 9.7
0.6 + 0.2
B.
BP, mm Hg
GFR,ml/min
(N = 6)(N = 6)
Control
128.0 + 3.4
1.0 0.3
NS
NS
Vasopressin
132.0 2.6
0.9 0.4
(N = 4)(N = 4)
Control
147.0 0.5
1.0 0.1
NS
NS
Vasopressin
144.0 + 4.8
0.6
C.
BP, mm Hg
GFR, mI/mm
(N = 7)
(N = 7)
Control
132.0 + 5.8
1.2 0.5
<0.005
NS
Norepinephrine
154.0 + 6.2
1.5 0.5
(N = 5)(N = 5)
Control
134.0 3.3
0.7 0.2
<0.005
NS
Norepinephrine
151.0 + 5.3
0.6 0.1
Results are listed as mean values SEM.
not in the patients with DI. Taken together, these
previous findings in man and the present results in
rats suggest that an endogenous source of vasopressin
is necessary for the in vivo demonstration of the an-
tidiuretic effect of beta adrenergic stimulation. These
results, therefore, do not provide support for a direct
tabular effect of isoproterenol on water permeability
in vivo.
In in vitro studies in dog medulla, isoproterenol was
found to increase cyclic AMP [20]. Since cyclic AMP
is the intracellular mediator of vasopressin, Beck et al
suggested that beta adrenergic stimulation may di-
rectly alter the water permeability of the renal tubule
[20]. Such in vitro results, however, may not be appli-
cable to the in vivo circumstance. In the present in
vivo studies the effect of isoproterenol to increase
medullary cyclic AMP, therefore, was examined in
intact Sprague-Dawley and DI rats. While isopro-
terenol increased medullary cyclic AMP in the intact
rats, no significant change was observed in the
Brattleboro homozygote rats with DI. These find-
ings, therefore, further support the conclusion that
the primary in vivo effect of beta adrenergic stimula-
tion to increase medullary cyclic AMP is dependent
0
Control Isoproterenol- Vasopressin-
rats treated rats treated rats
Fig. 2. Effleci 0/ isoproterenol (hatchedbars) and vasopressin (solid
bars) on (upper panel) and medullary cyclic AMP (lower panel)
in diabetes insipidus rats.
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Fig. I. Effect of isoproterenol (hatched bars) and vasopressin (solid
bars) to increase U0,.,,. (upper panel) and medullary cyclic AMP
(lower panel) as compared to waler-diuresing Sprague-Dawley rats
(clear bar). The Ufl,,,,, in this and subsequent figures represents the
value at the time of removal of the kidneys for measuring medul-
lary cyclic AMP.
with norepinephrine. The latter value was actually
significantly increased (P < 0.01). The mean values
for Uosm and medullary cyclic AMP are shown in
Figure 4.
Discussion
In the present study, the effect of catecholamines
on renal excretion was examined in intact Sprague-
Dawley rats and rats with congenital pituitary diabe-
tes insipidus (DI). Beta adrenergic stimulation with
isoproterenol infused i.v. diminished arterial pressure
(BP) and glomerular filtration rate (GFR) in both
groups of rats. Such a fall in renal BP and GFR
might have been expected to increase urinary os-
molality (Uo,.m) in both groups of rats [19]. In the
present study, however, an increase in Uoam was ob-
served only in the Sprague-Dawley but not the DI
rats. These findings are similar to those observed in
normal subjects and in patients with pituitary DI
[14]. In this previous study in humans [14], isopro-
terenol diminished arterial pressure to a comparable
degree in both groups of subjects, and yet an increase
in Uosm was observed only in the normal subjects and
600
400 -
200 - 1'
0-
15.0 -
75
5,
00
0
E
0
a-
U>0U0,
>Eit—..
-00
P<0.05
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acutely hypophysectomized dog [5]. There thus seems
to be some evidence that a small residual effect of
beta adrenergic stimulation might persist in the ab-
sence of endogenous vasopressin, even though such
was not the case in the present study. In any case, the
primary event appears to be the effect of beta adren-
ergic stimulation to increase the endogenous release
of vasopressin, which then activates medullary
adenylate cyclase and generates cyclic AMP. It was
conceivable that beta adrenergic stimulation could
increase a pool of medullary cyclic AMP which is
unrelated to water permeability of collecting ducts.
Such a finding might, therefore, explain the in vitro
observation that isoproterenol increases medullary
cyclic AMP [20]. There was, however, no evidence
for this conclusion in the present study since beta
adrenergic stimulation did not increase medullary cy-
clic AMP in the Dl rats. In addition, as a control
observation, the administration of exogenous vaso-
pressin was shown to increase both cyclic AMP con-
centration and Uogm in the DI rats.
The second part of this study demonstrated that
norepinephrine infusions in Sprague-Dawley rats
(Group 4) caused a decrease in Uosm and medullary
cyclic AMP, while norepinephrine administration to
on the release of endogenous vasopressin. This con-
clusion is compatible with the in vitro results of
Kurokawa and Massry [21], who failed to demon-
strate a rise in cyclic AMP with isoproterenol in
isolated rat medullary epithelial cells. Taken to-
gether, therefore, it seems reasonable to conclude
that beta adrenergic stimulation increases medullary
cyclic AMP and decreases renal water excretion pri-
marily by stimulating the release of vasopressin. This
conclusion is also compatible with the results in dogs
in which either baroreceptor denervation [7, 8] or
acute hypophysectomy [5, 6] has been found to vir-
tually abolish the antidiuresis of beta adrenergic stim-
ulation.
It should be mentioned that if larger doses of
isoproterenol are administered to any species, the
resultant greater fall in arterial pressure and GFR
could increase Uogm in the absence of endogenous
vasopressin. Although BP and GFR were not mea-
sured, this seems to be the likely explanation for the
small mean rise in Uosm (103 to 183 mOsm/kg of
water) which occurred in a previous study during
isoproterenol administration to Dl rats under pento-
barbital anesthesia [12]. It is also of note that isopro-
terenol infusion was associated with a slight increase
in Uosm (78 to 97 mOsm/kg of water) in the
I
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Fig. 3. EJJect of norepinephrine to decrease U0,i,, (upper panel) and
,nedullarr cyclic AMP (lower panel) in Sprague-ba wley rats.
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Control Norepinephrine-
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Fig. 4. Failure of norepinephrine to decrease either L10i,,,, (upper
panel) or ,nedullarv cyclic AMP (lower panel) in diabetes insipidus
rats receiving vasopressin.
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DI rats receiving a constant infusion of vasopressin
(Group 5) failed to do so. This finding suggests that
the major effect of norepinephrine on Uogm and med-
ullary cyclic AMP in the Sprague-Dawley rats was
the result of suppression of endogenous vasopressin
secretion.
The correlation between Uosm and medullary cyclic
AMP in the Sprague-Dawley and DI rats was prob-
ably affected by other factors in addition to vasopres-
sin. The Sprague-Dawley rats in Group 4 undoubt-
edly had a higher medullary interstitial fluid
osmolality than did the DI rats in Group 5. This
probably accounted for the higher control Uo8m in
the Sprague-Dawley rats compared to the DI rats
receiving the constant infusion of vasopressin. The
studies of Harrington and Valtin [22] indicate that a
longer period of treatment with vasopressin would
have induced much higher Uosm levels in the DI rats.
In the present acute studies, however, Usm was near
the maximum that could be achieved during a brief
infusion of vasopressin in the DI rat. This helps to
explain why Uogm went no higher in these rats after
norepinephrine administration, in spite of a signifi-
cant rise in medullary cyclic AMP. Another con-
clusion arising from this observation is that the urine
concentrating defect in the DI rats was not attribut-
able to a lack of cyclic AMP in the medulla. The
question remains as to why medullary cyclic AMP
increased in the DI rats after they were given norepi-
nephrine (Fig. 4). The present study provides no ex-
planation for this finding, but a possibility is that
norepinephrine reduces the rate of clearance from the
medulla, perhaps by decreasing medullary blood
flow. Whatever the mechanism, the results indicate
that norepinephrine enhances, rather than inhibits,
the ability of vasopressin to increase medullary cyclic
AMP content. Therefore, there is no evidence from
this study that norepinephrine causes a diuresis by
inhibiting the action of vasopressin to increase med-
ullary cyclic AMP concentration.
It has been suggested that there is a particular ratio
between the dose of norepinephrine and vasopressin
which must be used to demonstrate in vivo com-
petitive inhibition [23]. It was on the basis of this
suggestion that the present doses of norepinephrine
and vasopressin were chosen. This same suggestion
has been made in man since norepinephrine caused a
water diuresis in water-loaded human subjects receiv-
ing submaxinial but not maximal doses of vasopres-
sin [13]. Although it was assumed in these studies
that endogenous vasopressin was maximally sup-
pressed by the water-loading, these results were not
reproducible in patients with pituitary DI [14]. This
finding [14] suggested that in the earlier study norepi-
nephrine had suppressed some residual endogenous
vasopressin in the normal subjects receiving sub-
maximal doses of vasopressin [13].
Thus, as with beta adrenergic stimulation, the pres-
ent in vivo results with norepinephrine failed to sup-
port a direct tubular effect of norepinephrine to sup-
press medullary cyclic AMP and thereby to interfere
with the tubular effect of vasopressin. The demon-
stration of such an effect in vitro [9—11, 20], therefore,
must be related either to relatively large doses or to
the in vitro conditions. The doses of norepinephrine
used in the present study increased arterial blood
pressure by about 20 mm Hg; therefore, the phys-
iologic significance of results using larger doses of
norepinephrine would be debatable. As with beta
adrenergic stimulation, these observed changes in ar-
terial pressure did not alter Uosm in the DI rats. In
this regard, the alterations in renal arterial pressure
which have been shown experimentally to alter renal
water excretion have been much larger [19, 24].
In summary, the present results have demonstrated
that the effect of alpha and beta adrenergic stimula-
tion to alter renal water excretion in the anesthetized
rat is dependent on the modulation of an endogenous
source of vasopressin, which then alters medullary
cyclic AMP concentration and renal tubular water
permeability. There was no evidence for a direct ef-
fect of these catecholamines on renal tubular water
permeability. Such an effect may, however, occur in
vitro at larger pharmacologic doses than can be used
in vivo. The physiologic significance of such an obser-
vation must, however, be questioned on the basis of
the present in vivo results.
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